|
. |
CHICAGO, July 16, 2008 NourishLife awarded exclusive license by Children’s Hospital & Research Center NourishLife announced today that it has entered into an exclusive license agreement with CHRCO Apraxia is a neurological disorder characterized by the inability to perform purposeful motor movements, despite having the desire and physical ability to perform the movements. Verbal apraxia affects the ability to produce normal sounds needed for speech. Experts believe the number of cases is increasing in this previously rare condition. It is estimated that up to 50% of children with autism spectrum disorders have verbal apraxia, although not all children with apraxia have autism. Statement from Dr. Bertram H. Lubin, President, Director of Medical Research, CHORI: “We are very pleased to license our technology to NourishLife. This company has demonstrated a strong commitment to working to provide a formulation that will be evaluated for the treatment of children with apraxia. We are very excited about the application of nutritional interventions for children with neurodevelopmental disorders. We believe NourishLife is an ideal partner to commercialize this technology.” Mark Nottoli, co-founder of NourishLife stated: “The anecdotal evidence reported by a large number of parents is encouraging. Of course, we cannot expect this formulation to help every child. But it appears that a significant percentage of these children being supplemented with an omega-3/antioxidant cocktail are experiencing positive results”. Further information is available at speechtrial.com Nottoli concluded: “We are pleased to be part of this project as it fits in perfectly with the mission and vision of NourishLife. As the father of four children, I am personally thrilled at the prospect of helping children who cannot talk, begin to speak.” About NourishLife: The PharmaOmega division of NourishLife (PharmaOmega.com) is becoming the web's premier source of omega-3 information, research and news. Working with some of the world’s leading research scientists, PharmaOmega creates effective, evidence-based specialty omega 3 nutrition products of the highest concentration, quality and purity. NourishLife is a privately held company located in the Chicago area. About CHRCO: Research efforts at Children’s Hospital & Research Center Oakland are coordinated through Children’s
Hospital Oakland Research Institute (CHORI). Children’s Hospital Oakland is Northern California’s only
freestanding and independent children’s hospital.
CHORI’s internationally renowned biomedical research facility brings together seven centers of excellence
that are devoted to Clinical and basic science research to treat and prevent disease. CHORI has
approximately 300 staff members and an annual budget of more than $49 million. The National Institutes of Press Contact:
|
|
 |
 |
 |
 |
 |
 |